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Abstract: 
Eosinophilic otitis media is actually a recent introduction.  These patients may manifest with sudden 
hearing loss.  There may be associated bronchial asthma and allergic rhinitis.  Diagnostic criteria of 
this condition are rather vague.  A review of literature shows that demonstration of eosinophils in 
the middle ear secretion of these patients could be considered to be pathognomonic of this 
condition. 
 
 
 
Introduction: 
 
Eosinophils are considered to be effectors for allergic reactions.  Eosinophilic otitis media 1 is a 
newly recognised entity causing intractable middle ear pathology.  This condition is characterised 
by excessive accumulation of eosinophils in the middle ear cavity and is associated with persistent 
middle ear effusion.  These patients usually suffer from bronchial asthma.  The first description of 
this condition should be credited to Koch 2 who first reported some patients with middle ear 
effusion which contained lots of eosinophils.  He also added that these secretions were highly 
viscous and the middle ear mucosa was pinkish in color.  The term eosinophilic otitis media was 
coined by Tomioka et al 3 in 1993. 
 
Pathophysiology: 
Pathophysiology of this condition is obviously allergy.  These patients commonly had associated 
allergic rhinitis and bronchial asthma.  Eosinophils could have been probably attracted to the middle 
ear cavity by the presence of IL 5 4 inside the middle ear cavity. 
 
Features of Eosinophilic otitis media 5: 
 
1.  Sudden deterioration of hearing 
2.  Bronchial asthma 
3.  Allergic rhinitis 
4.  Intractable otitis media 
5.  Persistent otorrhoea 
 
 
Incidence: 
 Incidence of eosinophlic otitis media is not clearly known.  Literature search puts it to be rather 
common cause of otitis media with effusion. 
 
Management: 
 
Patients diagnosed with this condition should be warned of the possibility of sudden deterioration of 
hearing. 
Administration of systemic / topical steroids 6 could be of benefit in these patients. 
Antihistamines and leukotreine receptor antogonists can also be used with benefit. 
Grommet insertion is indicated in patients with acute sudden hearing loss. 
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